Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linqi Zhang

Showing results (201-210 of 279) with videos related to

Pageof 28
Sort By:
Emerging Microbes & Infections|May 28, 2019
Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infectionWenxu Jia, Rudragouda Channappanavar, Chao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2022
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralizationSisi Shan, Shitong Luo, Ziqing Yang, et al.
Cell Research|July 10, 2013
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4Nianshuang Wang, Xuanling Shi, Liwei Jiang, et al.
Stem Cell Research|November 26, 2020
A safety consideration of mesenchymal stem cell therapy on COVID-19Yajun Cao, Hongyan Wu, Wanli Zhai, et al.
Frontiers in Immunology|July 5, 2022
SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2Ruoke Wang, Qi Zhang, Rui Zhang, et al.
Cell Reports|July 12, 2018
Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike GlycoproteinSenyan Zhang, Panpan Zhou, Pengfei Wang, et al.
Plos One|December 22, 2006
Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirusTaisheng Li, Jing Xie, Yuxian He, et al.
EJNMMI Research|September 10, 2024
Role of [<sup>18</sup>F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [<sup>18</sup>F]FDG PET/CTJiucen Liang, Shuqin Jiang, Jingjing Song, et al.
Science China. Life Sciences|March 17, 2026
A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virusQingtai Liang, Qian-Ying Zhu, Xin-Yan Fang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 15, 2025
Diagnostic performance of [<sup>18</sup>F]FAPI-04 PET/CT in suspected recurrent hepatocellular carcinoma: prospective comparison with contrast-enhanced CT/MRIJiucen Liang, Shaojuan Weng, Jing Zhang, et al.
Pageof 28

Showing results (201-210 of 279) with videos related to

Sort By:
Pageof 28
Emerging Microbes & Infections|May 28, 2019
Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infectionWenxu Jia, Rudragouda Channappanavar, Chao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2022
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralizationSisi Shan, Shitong Luo, Ziqing Yang, et al.
Cell Research|July 10, 2013
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4Nianshuang Wang, Xuanling Shi, Liwei Jiang, et al.
Stem Cell Research|November 26, 2020
A safety consideration of mesenchymal stem cell therapy on COVID-19Yajun Cao, Hongyan Wu, Wanli Zhai, et al.
Frontiers in Immunology|July 5, 2022
SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2Ruoke Wang, Qi Zhang, Rui Zhang, et al.
Cell Reports|July 12, 2018
Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike GlycoproteinSenyan Zhang, Panpan Zhou, Pengfei Wang, et al.
Plos One|December 22, 2006
Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirusTaisheng Li, Jing Xie, Yuxian He, et al.
EJNMMI Research|September 10, 2024
Role of [<sup>18</sup>F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [<sup>18</sup>F]FDG PET/CTJiucen Liang, Shuqin Jiang, Jingjing Song, et al.
Science China. Life Sciences|March 17, 2026
A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virusQingtai Liang, Qian-Ying Zhu, Xin-Yan Fang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 15, 2025
Diagnostic performance of [<sup>18</sup>F]FAPI-04 PET/CT in suspected recurrent hepatocellular carcinoma: prospective comparison with contrast-enhanced CT/MRIJiucen Liang, Shaojuan Weng, Jing Zhang, et al.
Pageof 28